Canoga Perkins' SyncMetra ® Network Connectivity Solution Enables Enterprise AI at the Edge, Powered by AMD FPGAs
Network connectivity solutions provider, Canoga Perkins today announced that its SyncMetra ultra-low, guaranteed latency offering for enterprise AI at the edge is powered by AMD Virtex™ UltraScale+™ FPGAs.
SyncMetra is Canoga Perkins' software-defined, IT-operated private 5G network transport solution that guarantees ultra-low latency, deterministic wireless communications for enterprise AI, industrial automation, and AR/VR applications. Providing performance and features that enable inference to take place on-premise, consolidating multiple sensor feeds and reducing total cost of ownership—the SyncMetra unlocks a new breed of Enterprise Edge AI applications.
Programmable, expandable, and software-defined, SyncMetra operates via a cloud-managed network orchestrator (SyncMetra Manager), access points, a SyncMetra switch, and a 5G operating system or core. This allows network owners and integrators to auto-provision network resources to enable several key applications.
Powered by AMD Virtex UltraScale+ FPGAs, SyncMetra brings engineered and bounded latency to market for time-critical applications, delivering the ability to optimally deploy networks and solutions for some of the most complex use cases facing enterprises today:
- Enterprise Edge AI: SyncMetra unlocks new abilities to scale enterprise AI deployments for a wide spectrum of inference-at-the-edge use cases, including physical security, retail, quality assurance and predictive maintenance.
- Industrial Automation: SyncMetra Private 5G with Time-Sensitive Networking (TSN) provides industrial network owners and integrators guaranteed, ultra-reliable low latency communication (URLLC) and packet delivery – and a programmable expandable alternative to Wi-Fi and current 5G for industrial automation use cases.
- AR/VR: SyncMetra provides specialized training facilities and their integrators the ability to configure and deploy single-server, on-premises communications solutions capable of delivering robust, mission-specific experiences to multiple, free-moving participants.
“The increasing complexity of emerging networks within industrial automation, enterprise AI and beyond required a transformative solution built to address those challenges,” said Gilles Garcia, senior director of business lead communications group at AMD. “AMD Virtex UltraScale+ devices are designed with exactly this type of innovation in mind, and we are proud that this collaboration with Canoga Perkins’ SyncMetra platform will enable the delivery of scalable, reprogrammable, and reliable connectivity solutions to empower IT departments and network operators alike.”
“We recognized early on that industrial automation and enterprise AI were being held back by current wireless technologies and the complexity of deploying ultra-reliable, guaranteed latency networks,” said Malik Arshad, president of Canoga Perkins. “With this in mind, we purpose-built SyncMetra to address these challenges head-on, leveraging industry-leading AMD FPGAs to deliver a transformative solution that redefines what’s possible.”
About Canoga Perkins
Founded in 1965, privately held Canoga Perkins has a long history of providing mission-critical, secure communications to service providers, the military, government agencies, and utilities. With more than 150,000 active network elements operating in Tier 1 service provider networks, Canoga Perkins is differentiated by the telco reliability of its products and its ability to anticipate and nimbly act on emerging IT trends.
AMD, UltraScale+, Virtex and combinations thereof are trademarks of Advanced Micro Devices, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414723827/en/
Contacts
Amber Flores
Canoga Perkins, Marketing
aflores@canogaperkins.net
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Logitech Announces Q4 and Full Fiscal Year 2025 Results29.4.2025 22:03:00 CEST | Press Release
SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2025 ended March 31, 2025. For Fiscal Year 2025: Sales were $4.55 billion, up 6 percent in US dollars and 7 percent in constant currency, compared to the prior year. GAAP operating income was $655 million, up 11 percent compared to the prior year. Non-GAAP operating income was $775 million, up 11 percent compared to the prior year. GAAP earnings per share (EPS) was $4.13, up 7 percent compared to the prior year. Non-GAAP EPS was $4.84, up 14 percent compared to the prior year. Cash flow from operations was $843 million. The year-ending cash balance was $1.5 billion. The Company returned $797 million of cash to shareholders through its annual dividend payment and share repurchases. For Q4 Fiscal Year 2025: Sales were $1.01 billion, flat in US dollars and up 2 percent in constant currency, compared
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene29.4.2025 21:32:00 CEST | Press Release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that were challenged by BeiGene in a post-grant review (PGR) proceeding. On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the ‘803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA® (zanubrutinib). On May 1, 2024, the USPTO granted BeiGene’s petition to institute the PGR. The USPTO’s Final Written Decision is appealable by Pharmacyclics. Commenting on the ruling, BeiGene General Counsel Chan Lee said: “We are pleased that the USPTO invalidated all challenged claims of the ‘803 patent. Today’s decision reinforces our belief th
One out of Three Secure Civil IDs Delivered Each Year Is Powered by Thales29.4.2025 16:50:00 CEST | Press Release
Each year, Thales powers one in three smart civil IDs (official electronic documents) issued worldwide, highlighting the company’s key role in shaping the future of identities and helping governments and citizens transition smoothly to digital. With its Civil Identity Suite, Thalesenables the issuance and management of both physical and digital identities, as well as all means of enrolling citizens and enabling seamless ID verification for access to services, both in-person and online. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429687137/en/ Thales Civil Id Suite (Photo: Thales Shutterstock) Thales, a global leader in advanced technologies and #1 global leader in ID documents, has recently earned the new title of #1 provider of Digital ID solutions as recognized by Juniper Research (2024). With unmatched experience and scale, Thales empowers governments to modernise their identity systems, ensuring they meet the deman
Andersen Global Enhances European Valuation Capabilities through Collaboration with Value & Risk Valuation Services29.4.2025 15:30:00 CEST | Press Release
Andersen Global continues to strengthen its valuation capabilities through a Collaboration Agreement with Value & Risk Valuation Services, a prominent European valuation firm headquartered in Germany with offices in Luxembourg and Austria. Founded in 1996, Value & Risk Valuation Services is a management-owned firm specializing in the valuation of financial assets across diverse asset classes and varying complexities. The firm also provides complementary services, including independent price verification (IPV), risk analysis, and transaction cost analysis. Since 2009, the company has been led by Gil Bender, who is dedicated to delivering high-quality, client-centric valuation solutions. As one of the few European providers offering external valuation services in compliance with the European Alternative Investment Fund Managers Directive (AIFMD), Value & Risk upholds the highest industry standards for regulatory compliance and service excellence. “Since our inception, we have focused on
Solving Border Control Staffing Challenges: Regula Launches an Ecosystem for Remote Document Examination29.4.2025 15:00:00 CEST | Press Release
Regula, a global developer of forensic devices and identity verification solutions, introduces an innovative solution designed to transform document examination processes, particularly in border control operations. Based on high-resolution photospectral scanners from the Regula 88XX product line, it enables highly accurate and reliable remote document authentication, effectively addressing the pressing issue of staffing shortages in border security. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429852027/en/ High-resolution photospectral scanner Regula 8880 for remote document verification (Photo: Regula) Traditionally, document authenticity experts needed to be physically present at each checkpoint. However, this requirement has become increasingly challenging due to current staffing constraints. For example, a recent European Commission report highlights gaps in the availability of certain specialized experts, notably
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom